Delamanid expanded access novel treatment of drug resistant tuberculosis
Roxana Rustomjee,1 Alimuddin Zumla2,31South African Medical Research Council, Cape Town, South Africa; 2Division of Infection and Immunity, University College London, London, UK; 3NIHR Biomedical Research Centre, University College Hospitals NHS Foundation Trust, London, UKAbstract: Tuberculosis (TB...
Main Authors: | Rustomjee R, Zumla A |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-10-01
|
Series: | Infection and Drug Resistance |
Online Access: | https://www.dovepress.com/delamanid-expanded-access-novel-treatment-of-drug-resistant-tuberculos-peer-reviewed-article-IDR |
Similar Items
-
Delamanid expanded access novel treatment of drug resistant tuberculosis [Corrigendum]
by: Rustomjee R, et al.
Published: (2016-04-01) -
The role of delamanid in the treatment of drug-resistant tuberculosis
by: Lewis JM, et al.
Published: (2015-05-01) -
Profile of delamanid for the treatment of multidrug-resistant tuberculosis
by: Szumowski JD, et al.
Published: (2015-01-01) -
Early experience of delamanid in extensively drug-resistant pulmonary tuberculosis
by: Vikas Marwah, et al.
Published: (2023-01-01) -
Advances of new drugs bedaquiline and delamanid in the treatment of multi-drug resistant tuberculosis in children
by: Hanzhao Zhu, et al.
Published: (2023-06-01)